These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23212097)

  • 1. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome.
    Nishida T; Tsuneyama K; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Nakanishi Y; Sasaki Y; Suzuki W; Iizuka S; Nagata M; Shimada T; Aburada M; Shimada Y; Imura J
    Lab Invest; 2013 Feb; 93(2):230-41. PubMed ID: 23212097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice.
    Watanabe S; Takahashi T; Ogawa H; Uehara H; Tsunematsu T; Baba H; Morimoto Y; Tsuneyama K
    Metab Syndr Relat Disord; 2017 May; 15(4):170-177. PubMed ID: 28358620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for analyzing metabolic syndrome-associated liver diseases.
    Tsuneyama K; Nishitsuji K; Matsumoto M; Kobayashi T; Morimoto Y; Tsunematsu T; Ogawa H
    Pathol Int; 2017 Nov; 67(11):539-546. PubMed ID: 29027308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model.
    Ichimura-Shimizu M; Kageyama T; Oya T; Ogawa H; Matsumoto M; Sumida S; Kakimoto T; Miyakami Y; Nagatomo R; Inoue K; Cheng C; Tsuneyama K
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Soejima Y; Fukusato T
    World J Gastroenterol; 2012 May; 18(19):2300-8. PubMed ID: 22654421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice.
    Murotomi K; Arai S; Uchida S; Endo S; Mitsuzumi H; Tabei Y; Yoshida Y; Nakajima Y
    Sci Rep; 2016 Mar; 6():22476. PubMed ID: 26932748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice.
    Shao W; Jargalsaikhan O; Ichimura-Shimizu M; Cai Q; Ogawa H; Miyakami Y; Atsumi K; Tomita M; Sutoh M; Toyohara S; Hokao R; Kudo Y; Oya T; Tsuneyama K
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.
    Radwan MM; Radwan BM; Nandipati KC; Hunter WJ; Agrawal DK
    Expert Rev Clin Immunol; 2013 Aug; 9(8):727-38. PubMed ID: 23971751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse).
    Takahashi T; Nishida T; Baba H; Hatta H; Imura J; Sutoh M; Toyohara S; Hokao R; Watanabe S; Ogawa H; Uehara H; Tsuneyama K
    Mol Clin Oncol; 2016 Aug; 5(2):267-270. PubMed ID: 27446562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.
    Itoh M; Suganami T; Nakagawa N; Tanaka M; Yamamoto Y; Kamei Y; Terai S; Sakaida I; Ogawa Y
    Am J Pathol; 2011 Nov; 179(5):2454-63. PubMed ID: 21906580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
    Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis-related progressive bridging fibrosis.
    Ichimura-Shimizu M; Omagari K; Yamashita M; Tsuneyama K
    Biosci Biotechnol Biochem; 2021 Mar; 85(4):941-947. PubMed ID: 33620426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma.
    Corbit KC; Wilson CG; Lowe D; Tran JL; Vera NB; Clasquin M; Mattis AN; Weiss EJ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.